|
Referenz |
Lieferant |
Beschreibung |
Einheit |
Preis exkl. MwSt. |
|
|
|
USP-1356960 |
USP |
Leflunomide (alph,aplpha,alpha-Trifluoro-5-methyl-4-isoxazolecarboxy-p-toluidide) 200 mg |
|
590.67 CHF
620.20 €
|
|
|
|
USP-1356971 |
USP |
Letrozole 200 mg |
|
474.67 CHF
498.40 €
|
|
|
|
USP-1356982 |
USP |
Letrozole Related Compound A - 4,4'-(1H-1,3,4-triazol-1-ylmethylene)dibenzonitrile 25 mg |
|
1,568.00 CHF
1,646.40 €
|
|
|
|
USP-1356993 |
USP |
Lauroyl Polyoxylglycerides 300 500 mg |
|
538.67 CHF
565.60 €
|
|
|
|
USP-1357001 |
USP |
L-Leucine 200 mg |
|
561.33 CHF
589.40 €
|
|
|
|
USP-1357045 |
USP |
Leflunomide Related Compound A - 4-trifluoromethyl)aniline 100 mg |
|
1,568.00 CHF
1,646.40 €
|
|
|
|
USP-1357056 |
USP |
Leflunomide Related Compound B - 2-Cyano-3-hydroxy-N-(4'-trifluoromethylphenyl)-crotone amide 20 mg |
|
1,604.00 CHF
1,684.20 €
|
|
|
|
USP-1357067 |
USP |
Leflunomide Related Compound C - N-(3'-Trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide 10 mg |
|
1,454.67 CHF
1,527.40 €
|
|
|
|
USP-1357090 |
USP |
Conjugated Linoleic Acids - Triglycerides 100 mg |
|
485.33 CHF
509.60 €
|
|
|
|
USP-1357103 |
USP |
Lacosamide CV ((+)-(R)-2-(Acetylamino)-N-benzyl-3-methoxypropanamide) (CONTROLLED IN USA) 250 mg |
|
1,054.40 CHF
1,107.12 €
|
|
|
|
USP-1357125 |
USP |
Lacosamide Related Compound B (2-Acetamido-3-(benzylamino)-3-oxopropyl acetate) 30 mg |
|
1,514.67 CHF
1,590.40 €
|
|
|
|
USP-1357147 |
USP |
Lacosamide Related Compound D (2-Amino-N-benzyl-3-methoxypropanamide oxalate) 30 mg |
|
1,514.67 CHF
1,590.40 €
|
|
|
|
USP-1357158 |
USP |
Lacosamide S-Enantiomer ((S)-2-(Acetylamino)-N-benzyl-3-methoxypropanamide) 30 mg |
|
1,481.33 CHF
1,555.40 €
|
|
|
|
USP-1357170 |
USP |
Lacosamide Related Compound F (2-Acetamido-N-benzyl-3-hydroxypropanamide) 30 mg |
|
1,514.67 CHF
1,590.40 €
|
|
|
|
USP-1357475 |
USP |
Latanoprost 50 mg |
|
3,586.67 CHF
3,766.00 €
|
|
|
|
USP-1357486 |
USP |
Latanoprost Related Compound A - Isopropy l(E)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)- 3-hydroxy-5-phenylpentyl]cyclopentyl]-5-heptenoate 50 mg |
|
2,085.33 CHF
2,189.60 €
|
|
|
|
USP-1357497 |
USP |
Latanoprost Related Compound B 25 mg |
|
1,944.00 CHF
2,041.20 €
|
|
|
|
USP-1357522 |
USP |
Latanoprost Related Compound D (COLD SHIPMENT REQUIRED) (Isopropyl (Z)-7-{(1R,2R,3R,5S)-2-[(R)-5-phenyl-3-(triethylsilyloxy)pentyl]-3,5-bis(triethylsilyloxy)cyclopentyl}hept-5-enoate) 25 mg |
|
1,924.00 CHF
2,020.20 €
|
|
|
|
USP-1357533 |
USP |
Latanoprost Related Compound E - (Z)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl}-5-heptenoic acid 25 mg |
|
1,944.00 CHF
2,041.20 €
|
|
|
|
USP-1358004 |
USP |
Leucovorin Calcium (Calcium N-[p-({[(6RS)-2-amino-5-formyl-5,6,7,8-tetrahydro-4-hydroxy-6-pteridinyl]methyl}amino)benzoyl]-L-glutamate (1:1)) 500 mg |
|
493.33 CHF
518.00 €
|
|
|
|
USP-1358503 |
USP |
Leuprolide Acetate - Biologic - (INTERNATIONAL COLD CHAIN SHIPMENT REQUIRED) 1,97 mg |
|
1,786.67 CHF
1,876.00 €
|
|
|
|
USP-1358784 |
USP |
Levalbuterol Hydrochloride (HCl) 200 mg |
|
482.67 CHF
506.80 €
|
|
|
|
USP-1358795 |
USP |
Levalbuterol Related Compound A - 4-(2-tert-butylamino-ethyl)-2-hydroxymethyl-phenol 30 mg |
|
1,648.00 CHF
1,730.40 €
|
|
|
|
USP-1358810 |
USP |
Levalbuterol Related Compound C (alpha-[{(1,1-Dimethylethyl)amino}methyl]-4-hydroxy-3-(methoxymethyl)-benzenemethanol) 30 mg |
|
1,568.00 CHF
1,646.40 €
|
|
|
|
USP-1358820 |
USP |
Levalbuterol Related Compound D (5-[2-(tert-Butylamino)-1-hydroxyethyl]-2-hydroxybenzaldehyde sulfate (2:1) (salt)) 30 mg |
|
1,568.00 CHF
1,646.40 €
|
|
|
|
USP-1358831 |
USP |
Levalbuterol Related Compound E - alpha-[{(1,1-Dimethylethyl)amino}methyl]-3-(ethoxy-methyl)-4-hydroxy-benzenemethanol 30 mg |
|
1,568.00 CHF
1,646.40 €
|
|
|
|
USP-1358842 |
USP |
Levalbuterol Related Compound F ((R)-1-[4-(Benzyloxy)-3-(hydroxymethyl)phenyl]-2-(tert-butylamino)ethan-1-ol) 30 mg |
|
1,648.00 CHF
1,730.40 €
|
|
|
|
USP-1358864 |
USP |
Levalbuterol Related Compound H - 4-[2-(tert-butylamino)-1-methoxyethyl]-2-(hydroxymethyl)phenol 10 mg |
|
1,648.00 CHF
1,730.40 €
|
|
|
|
USP-1359302 |
USP |
Levamisole Hydrochloride ((-)-2,3,5,6-Tetrahydro-6-phenylimidazo[2,1-b]thiazole monohydrochloride) 125 mg |
|
385.33 CHF
404.60 €
|
|
|
|
USP-1359404 |
USP |
Levetiracetam 200 mg |
|
649.33 CHF
681.80 €
|
|
|
|
USP-1359415 |
USP |
Levetiracetam Racemic Mixture 15 mg |
|
1,429.33 CHF
1,500.80 €
|
|
|
|
USP-1359426 |
USP |
Levetiracetam Related Compound A - (S)-N(1-amino-1-oxobutan-2-yl)-4-chlorobutanamide 20 mg |
|
1,604.00 CHF
1,684.20 €
|
|
|
|
USP-1359437 |
USP |
Levetiracetam Related Compound B - (S)-2-aminobutanamide Hydrochloride 20 mg |
|
1,568.00 CHF
1,646.40 €
|
|
|
|
USP-1359506 |
USP |
Levmetamfetamine CII (75 mg) (CONTROLLED IN GERMANY) 75 mg |
|
536.00 CHF
562.80 €
|
|
|
|
USP-1359801 |
USP |
Levobunolol Hydrochloride (HCl) 200 mg |
|
460.00 CHF
483.00 €
|
|
|
|
USP-1359856 |
USP |
Levocabastine Hydrochloride (HCl) 50 mg |
|
356.00 CHF
373.80 €
|
|
|
|
USP-1359867 |
USP |
Levocabastine Related Compound A - 1-[cis-4-cyano-4-(4-fluorophenyl)cyclohexyl]-4-phenylpiperidine-4-carboxylic acid hydrochloride 50 mg |
|
617.33 CHF
648.20 €
|
|
|
|
USP-1359903 |
USP |
Levocarnitine 400 mg |
|
485.33 CHF
509.60 €
|
|
|
|
USP-1359925 |
USP |
Levocarnitine Related Compound A - 2-propen-1-aminium, 3-carboxy-N,N,N-trimethyl-,chloride 100 mg |
|
1,557.33 CHF
1,635.20 €
|
|
|
|
USP-1359958 |
USP |
Levocetirizine Amide ((R)-2-(2-{4-[(4-Chlorophenyl)phenylmethyl]piperazin-1-yl}ethoxy)acetamide) 75 mg |
|
1,498.67 CHF
1,573.60 €
|
|
|
|
USP-1359969 |
USP |
Levocetirizine Dihydrochloride ((2-{4-[(R)-(4-Chlorophenyl)phenylmethyl]piperazin-1-yl}ethoxy)acetic acid dihydrochloride) 200 mg |
|
474.67 CHF
498.40 €
|
|
|
|
USP-1361009 |
USP |
Levodopa 200 mg |
|
474.67 CHF
498.40 €
|
|
|
|
USP-1361010 |
USP |
Levodopa Related Compound A - 3-(3,4,6-Trihydroxyphenyl)-alanine 50 mg |
|
1,568.00 CHF
1,646.40 €
|
|
|
|
USP-1362103 |
USP |
Levofloxacin ((-)-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4benzoxazine-6-carboxylic acid, hemihydrate) 200 mg |
|
474.67 CHF
498.40 €
|
|
|
|
USP-1362114 |
USP |
Levofloxacin Related Compound A - (S)-9-fluoro-2,3-dihydro-3-methyl-10-(piperazin-1-yl)-7-oxo-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid 25 mg |
|
1,568.00 CHF
1,646.40 €
|
|
|
|
USP-1362125 |
USP |
Levofloxacin Related Compound B - (S)-9,10,difluro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid 35 mg |
|
1,454.67 CHF
1,527.40 €
|
|
|
|
USP-1362136 |
USP |
Levofloxacin Related Compound C - (S)-ethyl 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylate 25 mg |
|
1,454.67 CHF
1,527.40 €
|
|
|
|
USP-1362158 |
USP |
Levofloxacin Related Compound E ((S)-9-Fluoro-2,3-dihydro-3-methyl-10-[2-(methylamino)ethylamino]-7-oxo-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid hydrochloride) 25 mg |
|
1,454.67 CHF
1,527.40 €
|
|
|
|
USP-1362169 |
USP |
Levofloxacin Related Compound F - ((S)-2,3-Dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid) 25 mg |
|
1,529.33 CHF
1,605.80 €
|
|
|
|
USP-1362307 |
USP |
Levomenol 100 mg |
|
416.00 CHF
436.80 €
|
|
